This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vetoquinol Names Dr. Eric M. Alsup As Country Manager, USA

FORT WORTH, Texas, April 3, 2013 /PRNewswire/ -- Vetoquinol USA announces the appointment of Dr. Eric M. Alsup as country manager for Vetoquinol USA. Alsup will replace Daniel Beauchamp, who is leaving Vetoquinol to pursue a new opportunity.


Alsup's 20-year career in animal health includes a number of U.S. and international management positions at Elanco Animal Health, including country director for Elanco Italy and head of global marketing for cattle. He left Elanco Animal Health to become vice president for cattle at Intervet, and continued as business unit head for cattle through the acquisitions by Schering-Plough and Merck. Alsup joined Vetoquinol in January of this year in a business development role for the Americas.

"Eric is a proven leader who has helped to grow some of the most highly regarded animal health companies in the world," said Tom Robitaille, group director of Vetoquinol Americas and head of the company's operations in the United States, Canada, Mexico and Brazil. "His experience in the veterinary community is a perfect fit for our organization, while his background in global marketing and sales initiatives adds to our already thriving United States team."

Alsup holds a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Doctor of Veterinary Medicine from Kansas State University. He assumes the responsibilities of country manager on the departure of Mr. Beauchamp, who has made a tremendous contribution to Vetoquinol in his roles as country manager in the U.S. and previously as country manager in Canada.

About Vetoquinol USA

Headquartered in Fort Worth, Texas, Vetoquinol USA—makers of Vetoquinol-branded products and the former Vet Solutions® product portfolio—is owned by Vetoquinol SA, a family-owned, independent French pharmaceutical company founded in 1933. Dedicated exclusively to animal health, Vetoquinol USA is focused on the development, production and marketing of FDA, EPA and AAFCO-regulated pharmaceutical, nutritional and dermatological products for dogs and cats. Vetoquinol USA's VET Business Unit specializes in anti-infective, pain management and cardio/nephrology products such as Surolan®, Vetprofen® and Azodyl®, and industry-leading nutritionals such as Laxatone® and Nutri-Cal®. The company's dermatological offerings include Vet Solutions® and Micro Pearls® Advantage shampoos and grooming products. For more information about Vetoquinol USA's products, visit

SOURCE Vetoquinol

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,802.62 +26.19 0.16%
S&P 500 1,982.45 -4.60 -0.23%
NASDAQ 4,752.7380 -28.5260 -0.60%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs